Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Feb:257:11-18.
doi: 10.1016/j.ejogrb.2020.11.068. Epub 2020 Dec 1.

Maternal, fetal and neonatal outcomes of large series of SARS-CoV-2 positive pregnancies in peripartum period: A single-center prospective comparative study

Najeh Hcini  1 , Fatma Maamri  2 , Olivier Picone  3 , Jean-Francois Carod  4 , Véronique Lambert  2 , Meredith Mathieu  2 , Gabriel Carles  2 , Léo Pomar  5
Affiliations
Observational Study

Maternal, fetal and neonatal outcomes of large series of SARS-CoV-2 positive pregnancies in peripartum period: A single-center prospective comparative study

Najeh Hcini et al. Eur J Obstet Gynecol Reprod Biol. 2021 Feb.

Abstract

Objective: To describe the proportions of asymptomatic, mild and severe diseases in infected pregnant women admitted for delivery. To compare maternal, fetal and neonatal outcomes of SARS-CoV-2 infected pregnant women with those of non-infected patients.

Study design: Through an universal PCR testing for SARS-COV-2 at admission (not symptoms-based), this prospective cohort study enrolled all pregnant women admitted for delivery between 16th of June and the 16th of August 2020 in the West French Guiana Hospital Center.

Results: 507 pregnant women were included during the study period, of which 137 (27 %) were infected with SARS-COV-2. On admission, only 34/137 (24.8 %) of these patients presented with clinical symptoms. Among asymptomatic women, 16 /103 (15 %) became symptomatic after diagnosis. Throughout the delivery hospitalization and follow-up, 87/137 (63.5 %) remained always asymptomatic, 45/137 (32.8 %) developed a mild COVID-19 and 5/137 (3.6 %) developed a severe infection. SARS-CoV-2 infected patients were more likely to have post-partum hemorrhage >500 mL (14.2 % vs 7.2 %, RR 2.0 [95 %CI 1.1-3.4]), to be transfused (5.5 % vs 1.1 %, RR 4.9 [1.5-16.6]), and to be hospitalized in ICU (3.6 % vs 0.8 %, RR 4.5 [95 %CI 1.1-18.6] than uninfected ones. Intra-uterine fetal demises were more common in infected mothers compared to controls (5.1 % vs 1.1 %, RR 4.7 [95 % CI 1.4-45.9). Among 108 neonates from infected mothers tested at birth, none tested positive (0/108). When tested between 25 and 42 h after delivery, 4/29 (13.7 %) were positive for SARS-CoV-2 RT-PCR on nasopharyngeal swabs and remained asymptomatic.

Conclusion: Pregnant women admitted for delivery and diagnosed with a SARS-COV-2 infection through an universal screening were symptomatic in only a quarter of cases. Their risks of post-partum hemorrhage, transfusion and admission to ICU were higher than those of uninfected patients. They also presented a higher risk of intra-uterine fetal demise. There were no other differences in maternal, obstetrical or neonatal outcomes.

Keywords: Maternal outcomes; Neonatal outcomes; Pregnancy; SARS-CoV-2 infection; Stillbirth.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors report no declarations of interest.

Figures

Fig. 1
Fig. 1
Flow diagram of CHOG maternity protocol during the SARS-CoV-2 epidemic.
Fig. 2
Fig. 2
Clinical course of 137 pregnant women diagnosed with SARS-CoV-2 infection at delivery.
See this image and copyright information in PMC

References

    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 doi: 10.1056/NEJMoa2001017. published online Jan 24. - DOI - PMC - PubMed
    1. Wong S.F., Chow K.M., Leung T.N., Ng W.F., Ng T.K., Shek C.C. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191(1):292–297. doi: 10.1016/j.ajog.2003.11.019. - DOI - PMC - PubMed
    1. Stockman L.J., Lowther S.A., Coy K., Saw J., Parashar U.D. SARS during pregnancy, United States. Emerg Infect Dis. 2004;10(9):1689–1690. doi: 10.3201/eid1009.040244. - DOI - PMC - PubMed
    1. Campbell K.H., Tornatore J.M., Lawrence K.E., Illuzzi J.L., Sussman L.S., Lipkind H.S. Prevalence of SARS-CoV-2 among patients admitted for childbirth in Southern Connecticut. JAMA. 2020;323(24):2520–2522. doi: 10.1001/jama.2020.8904. [published online ahead of print, 2020 May 26] - DOI - PMC - PubMed
    1. Khalil A., Hill R., Ladhani S., Pattisson K., O’Brien P. Severe acute respiratory syndrome coronavirus 2 in pregnancy: symptomatic pregnant women are only the tip of the iceberg. Am J Obstet Gynecol. 2020 doi: 10.1016/j.ajog.2020.05.005. Published online May 7. - DOI - PMC - PubMed

Publication types

MeSH terms